People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Digitalsmiths Corp | — | Other Technology | Series A | $18.9M | $187.3M | 2011 |
| SOMAVAC Medical Solutions, Inc. | — | Healthtech | Series A | $16.2M | $31.6M | 2016 |
| SweetBio, Inc. | — | Other Health Care | Series A | $13.6M | $7.7M | 2018 |
| SwineTech, Inc. | — | Other Technology | Series A | $13.0M | $17.0M | 2024 |
| Restore Medical Solutions, Inc. | — | Other Health Care | Series A | $8.5M | $84.0M | 2012 |
| Dev/Con Detect, Inc. | — | Other Technology | Series A | $5.6M | $28.8M | 2018 |
| OneClickShip, Inc. | — | Other Technology | Series A | $5.3M | $70.3M | 2019 |
| iYOTAH Solutions, Inc. | — | Other Technology | Seed | $3.1M | $20.6M | 2023 |
| Traklok Corp | — | Other Technology | Seed | $2.0M | $10.2M | 2009 |
| Computable Genomix, LLC | — | Other Technology | Pre-Seed | $230K | $9.7M | 2010 |
Jan Bouten at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jan Bouten on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Walker | 1 | 11 |
| Maria Cirino | 1 | 10 |
| Wright Steenrod | 1 | 9 |
| Dan O'Brien | 1 | 8 |
| Gary Stevenson | 1 | 7 |
| Daphne Carmeli | 1 | 4 |
| Ben Weinberger | 1 | 4 |
| Matthew Berry | 1 | 4 |
| Dean Hatton | 1 | 4 |
| Eric Mathews | 1 | 3 |
| William Wheaton | 1 | 3 |
| Glenn Argenbright | 1 | 3 |
| Glen Coleman | 1 | 3 |
| David Habiger | 1 | 3 |
| William G. Martin | 1 | 2 |
| Kevin Graff | 1 | 2 |
| Esra Roan | 1 | 2 |
| Richard H. Cody | 1 | 1 |
| I. Michael Wolfe | 1 | 1 |
| Fredrick M. Whitmeyer, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.